ChadAlanReichardMD

PubMed

• 12 citations
  Gut Microbiome-Dependent Metabolic Pathways and Risk of Lethal Prostate Cancer: Prospective Analysis of a PLCO Cancer Screening Trial Cohort
  Chad A. Reichard, Bryan Naelitz, Zeneng Wang, Xun Jia, Jianbo Li, Meir J. Stampfer, Eric A. Klein, Stanley L. Hazen, Nima Sharifi> ;Cancer Epidemiology, Biomarkers & Prevention. 2021 Oct 28
• 10 citations
  Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8-10) prostate cancer treated primarily by radical prostatectomy.
  Lamont Wilkins, Jeffrey J. Tosoian, Chad A. Reichard, Debasish Sundi, Weranja Ranasinghe, Ridwan Alam, Zeyad Schwen, Chandana A. Reddy, M.E. Allaf, John W. Davis, Bria...> ;Cancer. 2021 May 1
• Impact of Definitive Local Therapy in Men with Primary Small Cell Prostate Carcinoma.
  Oluchi Oke, Weranja Ranasinghe, Chad Tang, Sherif G. Shaaban, Lianchun Xiao, Chad A. Reichard, Mitchell S. Anscher, Brian F. Chapin, Ana Aparicio> ;European Urology. 2021 Apr 3
• 7 citations
  Urolithiasis in complicated inflammatory bowel disease: a comprehensive analysis of urine profile and stone composition
  Fabio Cesar Miranda Torricelli, Chad Reichard, Manoj Monga> ;International Urology and Nephrology. 2021 Feb 1
• 21 citations
  Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional Therapies.
  Weranja Ranasinghe, Daniel D. Shapiro, Hyunsoo Hwang, Xuemei Wang, Chad A. Reichard, Mohamed A Elsheshtawi, Mary Achim, Tharakeswara K. Bathala, Chad Tang, Ana Aparici...> ;European Urology. 2021 Feb 1
• 7 citations
  Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate Cancer.
  Weranja Ranasinghe, Chad A. Reichard, Yaw A. Nyame, Debasish Sundi, Jeffrey J. Tosoian, Lamont Wilkins, Ridwan Alam, Mary Achim, Xuemei Wang, Andrew J. Stephenson, Eri...> ;The Journal of Urology. 2020 Oct 1
• 5 citations
  Determining Clinically Based Factors Associated With Reclassification in the Pre-MRI Era using a Large Prospective Active Surveillance Cohort
  Justin R. Gregg, John W. Davis, Chad A. Reichard, Xuemei Wang, Mary Achim, Brian F. Chapin, Louis L. Pisters, Curtis A. Pettaway, John F. Ward, Seungtaek Choi, Quynh N...> ;Urology. 2020 Apr 1
• 41 citations
  HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer
  Jason W.D. Hearn, Christopher Sweeney, Nima Almassi, Chad A. Reichard, Chandana A. Reddy, Hong Li, Brian P. Hobbs, David F. Jarrard, Yu-Hui Chen, Robert Dreicer, Jorge...> ;JAMA Oncology. 2020 Apr 1
• 29 citations
  Radical prostatectomy or radiotherapy for high- and very high-risk prostate cancer: a multidisciplinary prostate cancer clinic experience of patients eligible for eith...
  Chad A. Reichard, Karen E. Hoffman, Chad Tang, Stephen B. Williams, Pamela K. Allen, Mary Achim, Deborah A. Kuban, Brian F. Chapin> ;BJU International. 2019 Nov 1
• 14 citations
  Impact of preoperative prostate magnetic resonance imaging on the surgical management of high-risk prostate cancer
  Janet Baack Kukreja, Tharakeswara K. Bathala, Chad A. Reichard, Patricia Troncoso, Scott E. Delacroix, Benjamin Davies, Scott E. Eggener, Marc C. Smaldone, M. Minhaj S...> ;Prostate Cancer and Prostatic Diseases. 2020 Mar 1
• Editorial Comment.
  Chad A Reichard, Brian F Chapin> ;Urology. 2019 Sep 1
• 12 citations
  Does time from diagnosis to treatment of high- or very-high-risk prostate cancer affect outcome?
  Chad A. Reichard, Yaw A. Nyame, Debasish Sundi, Jeffrey J. Tosoian, Lamont Wilkins, Ridwan Alam, Mary Achim, Xuemei Wang, Andrew J. Stephenson, Eric A. Klein, Ashley E...> ;BJU International. 2019 Aug 1
• 9 citations
  Management of cT4 Prostate Cancer.
  Weranja Ranasinghe, Chad A. Reichard, Tharakeswara K. Bathala, Brian F. Chapin> ;European Urology Focus. 2020 Mar 15
• 1 citations
  Treatment of the Primary Tumor in Metastatic Hormone-sensitive Prostate Cancer: Not Yet Ready for Prime Time as the Standard of Care.
  Weranja Ranasinghe, Chad A. Reichard, Brian F. Chapin> ;European Urology. 2019 Nov 1
• 2 citations
  Prediction of Organ-confined Disease in High- and Very-high-risk Prostate Cancer Patients Staged with Magnetic Resonance Imaging: Implications for Clinical Trial Design.
  Chad A. Reichard, Janet Baack Kukreja, Justin R. Gregg, Tharakeswala K. Bathala, Mary Achim, Xuemei Wang, John W. Davis, Quynh Nhu Nguyen, Brian F. Chapin> ;European Urology Focus. 2021 Jan 1
• 35 citations
  Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centers.
  Debasish Sundi, Jeffrey J. Tosoian, Yaw A. Nyame, Ridwan Alam, Mary Achim, Chad A. Reichard, Jianbo Li, Lamont Wilkins, Zeyad Schwen, Misop Han, John W. Davis, Eric A....> ;Cancer. 2019 Feb 1
• 5 citations
  Diet quality and Gleason grade progression among localised prostate cancer patients on active surveillance.
  Justin R. Gregg, Jiali Zheng, David S. Lopez, Chad A. Reichard, Gladys Browman, Brian F. Chapin, Jeri Kim, John J. Davis, Carrie R. Daniel> ;British Journal of Cancer. 2019 Jan 25
• 10 citations
  Coffee, Caffeine Metabolism Genotype and Disease Progression in Patients with Localized Prostate Cancer Managed with Active Surveillance.
  Justin R. Gregg, David S. Lopez, Chad A. Reichard, Jiali Zheng, Wenhui Wu, Yuanqing Ye, Brian F. Chapin, Jeri Kim, Carrie R. Daniel, John J. Davis> ;The Journal of Urology. 2019 Feb 1
• 5 citations
  Emerging role of cytoreductive prostatectomy in patients with metastatic disease.
  Yasmeen Jaber, Chad A. Reichard, Brian F. Chapin> ;Translational Andrology and Urology. 2018 Sep 1
• 30 citations
  Trends and disparities in the use of neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma
  Jonathan J. Duplisea, Ross J. Mason, Chad A. Reichard, Roger Li, Yu Shen, Stephen A. Boorjian, Colin P.N. Dinney> ;Canadian Urological Association Journal = Journal De L'association Des Urologues Du Canada. 2018 Jul 30
• 13 citations
  Radical Prostatectomy in Metastatic Castration-resistant Prostate Cancer: Feasibility, Safety, and Quality of Life Outcomes
  Chad A. Reichard, Justin R. Gregg, Mary Achim, Ana Aparicio, Curtis A. Pettaway, Louis L. Pisters, John F. Ward, John W. Davis, Brian F. Chapin> ;European Urology. 2018 Aug 1
• 1 citations
  Can Focal Therapy Replace Radical Therapy for Prostate Cancer? Against Focal Therapy.
  Chad A. Reichard, Brian F. Chapin> ;European Urology Focus. 2018 Feb 10
• 7 citations
  Impact of 5α-Reductase Inhibitors on Disease Reclassification among Men on Active Surveillance for Localized Prostate Cancer with Favorable Features
  Charles Dai, Vishnu Ganesan, Joseph Zabell, Yaw A. Nyame, Nima Almassi, Daniel Greene, Daniel Hettel, Chad A. Reichard, Samuel Haywood, Hans Arora, Anna Zampini, Alice...> ;The Journal of Urology. 2018 Feb 1
• 44 citations
  HSD3B1 and Response to a Nonsteroidal CYP17A1 Inhibitor in Castration-Resistant Prostate Cancer.
  Nima Almassi, Chad A. Reichard, Jianbo Li, Carly Russell, Jaselle Perry, Charles J. Ryan, Terence W. Friedlander, Nima Sharifi> ;JAMA Oncology. 2017 Oct 12
• 48 citations
  Association of HSD3B1 Genotype With Response to Androgen-Deprivation Therapy for Biochemical Recurrence After Radiotherapy for Localized Prostate Cancer.
  Jason W.D. Hearn, Wanling Xie, Mari Nakabayashi, Nima Almassi, Chad A. Reichard, Mark Pomerantz, Philip W. Kantoff, Nima Sharifi> ;JAMA Oncology. 2017 Oct 12
• Join now to see all